|
Mar 11
|
Stocks to Watch Tuesday: Tesla, Southwest, Oracle, Illumina
|
|
Mar 10
|
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
|
|
Mar 10
|
Illumina lowers outlook due to China sales ban, to cut $100 million in costs
|
|
Mar 10
|
Illumina addresses recent developments in China
|
|
Mar 10
|
Why Illumina, Inc. (ILMN) Is Plunging So Far In 2025
|
|
Feb 24
|
ILMN Stock Might Rise From Collaboration With Broad Clinical Labs
|
|
Feb 24
|
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
|
|
Feb 24
|
Trump’s Early Policy Moves Create New Headaches for This Biotech Heavyweight
|
|
Feb 21
|
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
|
|
Feb 20
|
Illumina teases transcriptome profiling tech ahead of 2026 launch
|
|
Feb 19
|
Cathie Wood Explains AI Growth Catalysts for Illumina (ILMN)
|
|
Feb 19
|
Illumina unveils first-of-its-kind spatial transcriptomics technology
|
|
Feb 18
|
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
|
|
Feb 18
|
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
|
|
Feb 14
|
Calvin Klein blacklisting sends chill through US business in China
|
|
Feb 13
|
Trump’s Cuts to Medical Research Are Hurting These Stocks
|
|
Feb 13
|
Jim Cramer on China’s Crackdown on Illumina (ILMN): “There Are Two Other Companies That Do What They Do”
|
|
Feb 12
|
Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts
|
|
Feb 12
|
Here's Why Illumina (ILMN) is a Strong Growth Stock
|
|
Feb 12
|
PacBio (PACB) Q4 Earnings Report Preview: What To Look For
|